Wolverine Trading
HRTX icon

Wolverine Trading’s Heron Therapeutics HRTX Stock Holding History

Wolverine Trading’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,500
Closed -$15.9K – 5203
2024
Q4 		$15.9K Buy
+10,500
New +$17K ﹤0.01% 5132
2024
Q2 		– Sell
-11,800
Closed -$32.7K – 4800
2024
Q1 		$32.7K Buy
11,800
+200
+2% +$503 ﹤0.01% 4284
2023
Q4 		$19.7K Buy
+11,600
New +$12.8K ﹤0.01% 4372
2022
Q1 		– Sell
-10,900
Closed -$101K – 5827
2021
Q4 		$101K Buy
+10,900
New +$111K ﹤0.01% 5086
2021
Q3 		– Sell
-11,200
Closed -$175K – 6537
2021
Q2 		$175K Sell
11,200
-15,900
-59% -$253K ﹤0.01% 5105
2021
Q1 		$415K Buy
27,100
+16,300
+151% +$291K ﹤0.01% 3993
2020
Q4 		$230K Buy
+10,800
New +$188K ﹤0.01% 4063
2020
Q3 		– Sell
-41,900
Closed -$597K – 4791
2020
Q2 		$597K Sell
41,900
-6,000
-13% -$98.6K ﹤0.01% 2541
2020
Q1 		$560K Buy
47,900
+6,300
+15% +$118K ﹤0.01% 2532
2019
Q4 		$983K Buy
41,600
+8,300
+25% +$184K ﹤0.01% 2434
2019
Q3 		$653K Sell
33,300
-11,600
-26% -$213K ﹤0.01% 2353
2019
Q2 		$835K Sell
44,900
-2,400
-5% -$47.9K ﹤0.01% 2210
2019
Q1 		$1.16M Buy
47,300
+11,100
+31% +$291K ﹤0.01% 1940
2018
Q4 		$860K Sell
36,200
-11,900
-25% -$327K ﹤0.01% 2106
2018
Q3 		$1.52M Sell
48,100
-9,900
-17% -$369K ﹤0.01% 1931
2018
Q2 		$1.6M Hold
58,000
– – ﹤0.01% 1790
2018
Q1 		$1.6M Buy
58,000
+39,100
+207% +$887K ﹤0.01% 1790
2017
Q4 		$342K Buy
+18,900
New +$308K ﹤0.01% 3436

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wolverine Trading's HRTX Position: Q1 2025 in Review

Wolverine Trading sold out of Heron Therapeutics (HRTX) in Q1 2025, closing a stake of 12,330 shares — an estimated $18.6K sold.

Wolverine Trading first reported a position in HRTX in Q1 2018 and held it in 14 quarters. The position peaked at $1.22M in Q2 2018. 164 funds tracked by Wall St. Rank hold HRTX as of Q1 2025.

  • Wolverine Trading reported no remaining Heron Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Wolverine Trading sold 12,330 Heron Therapeutics shares in Q1 2025, an estimated $18.6K.
  • Wolverine Trading first reported a position in Heron Therapeutics in Q1 2018 and held it in 14 quarters.
  • Wolverine Trading's Heron Therapeutics position peaked at $1.22M in Q2 2018.
  • 164 funds tracked by Wall St. Rank held Heron Therapeutics as of Q1 2025.

Based on Wolverine Trading's 13F filing for Q1 2025, filed 15 May 2025.